title: 2.5 year remission of AIDS-associated progressive multifocal leukoencephalopathy with combined antiretroviral therapy.
authors.forename: B
authors.initials: B
authors.lastname: Elliot
authors.forename: I
authors.initials: I
authors.lastname: Aromin
authors.forename: R
authors.initials: R
authors.lastname: Gold
authors.forename: T
authors.initials: T
authors.lastname: Flanigan
authors.forename: M
authors.initials: M
authors.lastname: Mileno
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy* / Q000276:immunology; D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D016049:Didanosine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D019469:Indinavir / Q000627:therapeutic use*; D007968:Leukoencephalopathy, Progressive Multifocal / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D008297:Male; D013997:Time Factors; D015215:Zidovudine / Q000627:therapeutic use*
chemical_list: D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D015215:Zidovudine; D019469:Indinavir; D016049:Didanosine